Can we stop ordering prostate-specific antigen screening tests?

JAMA Intern Med. 2013 May 27;173(10):847-8. doi: 10.1001/jamainternmed.2013.1164.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / blood*
  • Biopsy
  • Defensive Medicine*
  • Direct Service Costs*
  • Early Detection of Cancer* / adverse effects
  • Early Detection of Cancer* / economics
  • Early Detection of Cancer* / methods
  • Humans
  • Informed Consent*
  • Male
  • Predictive Value of Tests
  • Prescriptions*
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / economics
  • Prostatic Neoplasms / immunology
  • Prostatic Neoplasms / prevention & control
  • United States
  • Unnecessary Procedures*

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen